Magellan Health Services logo

Magellan Health Services

North America, Connecticut, United States, Avon

Description

Magellan Health Services is a healthcare management organization that focuses on managing behavioral healthcare and diagnostic imaging.

Investor Profile

Magellan Health Services has made 3 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Convertible Note (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Fitness
  • Mental Health
  • Mhealth
  • Wellness
  • Medical
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Magellan Health Services frequently co-invest with?

Katalyst Ventures
North America, California, United States, San Francisco
Co-Investments: 1
SG
North America, California, United States, Long Beach
Co-Investments: 1
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 1
Stony Lonesome Group
North America, Florida, United States, Tampa
Co-Investments: 1
Dreamit Ventures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
111° West Capital
North America, Wyoming, United States, Alpine
Co-Investments: 1

What are some of recent deals done by Magellan Health Services?

NeuroFlow

Philadelphia, Pennsylvania, United States

NeuroFlow is a HIPAA compliant digital health platform that optimizes the way behavioral healthcare is delivered, tracked, and assessed.

FitnessHealth CareMental HealthmHealthWellness
Series BJan 12, 2021
Amount Raised: $20,000,000
Arine

San Francisco, California, United States

Arine optimizes medications and improves human health through data-driven clinical services.

BiotechnologyHealth CareMedicalPharmaceutical
Series AJan 11, 2021
Amount Raised: $11,000,000
Click Therapeutics

New York, New York, United States

Click Therapeutics delivers safe and effective digital treatments to patients in need.

BiotechnologyHealth CareMedical DevicePharmaceuticalTherapeutics
Convertible NoteApr 5, 2017
Amount Raised: $3,700,000